SOBR Safe : Investor Presentation

Forward Looking Statements

This presentation of SOBR Safe, Inc. contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. The Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing Sections. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.

NASDAQ: SOBR | 2

SOBRsafe Foundational Technology

SOBRsafe has developed a proprietary transdermal technology that greatly simplifies alcohol detection process.

Transdermal Detection Technology

• Combines NIAAA-awarded gas sensor with proprietary algorithms to capture alcohol vapor emitted through pores
• Top tier detection accuracy standard at 0.02 BrAC baseline
• Accuracy approaches 99% at heavy consumption levels
• Detects 2-3x faster than other transdermals
• Detects for an extended period vs. breathalyzers
• Robust IP protection

NASDAQ: SOBR | 5

Disrupting the Alcohol Detection Status Quo

Transformative solutions for both point-of-care screening and remote monitoring.

NASDAQ: SOBR | 7

Addressable Market Verticals

Targeting market verticals in order of highest expected adoption rates, shortest sales cycle.

Licensing / Integration Potential

Streaming alcohol data into 3rd party records management software.

Building SOBRsafe tech into 3rd party hardware.

Augmenting 3rd party product suites.

NASDAQ: SOBR | 8

Behavioral Health Applications

Targeting substance recovery and mental health providers that perform procedural screening / monitoring functions.

USE CASE

• SOBRcheck for medication stations
• SOBRsure for outpatient monitoring

OPERATIONAL BENEFITS

• Time-stampedmeds delivery
• Client ID biometrically verified
• Seamless data input to EMR
• Positive reinforcement, not policing

CUSTOMER EXPERIENCE

• SOBRcheck has been an invaluable tool for us. It empowers us to verify the absence of alcohol in a rapid, accurate way, replacing breathalyzers for our everyday use. "
• • Oceanfront Recovery President and COO Keenen Diamond

NASDAQ: SOBR | 9

Justice Applications

Targeting agencies that service the justice system which require mandatory screening / monitoring functions.

USE CASE

• SOBRcheck for access point screening

OPERATIONAL BENEFITS

• Real-timealcohol results
• Seamlessly digitized records
• 4x faster throughput
• Efficiencies allocated to recovery

CUSTOMER EXPERIENCE

• The technology is much faster and more sanitary than breathalyzers, and with its biometric identity verification it
  lets our employees always know 'who is who' - even with a constantly changing clientele. "
• • Alternatives, Inc. CEO Dave Armstrong

NASDAQ: SOBR | 10